Guideline-Recommended Medications and Physical Function in Older Adults with Multiple Chronic Conditions

Overview

Journal J Am Geriatr Soc

Specialty Geriatrics

Date 2017 Sep 15

PMID 28905359

Citations 4

Authors

Gail McAvay

Heather G Allore

Andrew B Cohen

Danijela Gnjidic

Terrence E Murphy

Mary E Tinetti

Affiliations

Soon will be listed here.

Abstract

Background/objectives: The benefit or harm of a single medication recommended for one specific condition can be difficult to determine in individuals with multiple chronic conditions and polypharmacy. There is limited information on the associations between guideline-recommended medications and physical function in older adults with multiple chronic conditions. The objective of this study was to estimate the beneficial or harmful associations between guideline-recommended medications and decline in physical function in older adults with multiple chronic conditions.

Design: Prospective observational cohort.

Setting: National.

Participants: Community-dwelling adults aged 65 and older from the Medicare Current Beneficiary Survey study (N = 3,273). Participants with atrial fibrillation, coronary artery disease, depression, diabetes mellitus, or heart failure were included.

Measurements: Self-reported decline in physical function; guideline-recommended medications; polypharmacy (taking <7 vs ≥7 concomitant medications); chronic conditions; and sociodemographic, behavioral, and health risk factors.

Results: The risk of decline in function in the overall sample was highest in participants with heart failure (35.4%, 95% confidence interval (CI) = 26.3-44.5) and lowest for those with atrial fibrillation (20.6%, 95% CI = 14.9-26.2). In the overall sample, none of the six guideline-recommended medications was associated with decline in physical function across the five study conditions, although in the group with low polypharmacy exposure, there was lower risk of decline in those with heart failure taking renin angiotensin system blockers (hazard ratio (HR) = 0.40, 95% CI = 0.16-0.99) and greater risk of decline in physical function for participants with diabetes mellitus taking statins (HR = 2.27, 95% CI = 1.39-3.69).

Conclusions: In older adults with multiple chronic conditions, guideline-recommended medications for atrial fibrillation, coronary artery disease, depression, diabetes mellitus, and heart failure were largely not associated with self-reported decline in physical function, although there were associations for some medications in those with less polypharmacy.

Citing Articles

Pharmacist-Led Management Model and Medication Adherence Among Patients With Chronic Heart Failure: A Randomized Clinical Trial.

Wang L, Zhao Y, Han L, Zhang H, Chen H, Liu A JAMA Netw Open. 2024; 7(12):e2453976.

PMID: 39705029 PMC: 11662253. DOI: 10.1001/jamanetworkopen.2024.53976.

Effect of Antihypertensive and Statin Medication Use on Muscle Performance in Community-Dwelling Older Adults Performing Strength Training.

Alturki M, Liberman K, Delaere A, De Dobbeleer L, Knoop V, Mets T Drugs Aging. 2021; 38(3):253-263.

PMID: 33543410 DOI: 10.1007/s40266-020-00831-5.

Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis.

Gallagher C, Nyfort-Hansen K, Rowett D, Wong C, Middeldorp M, Mahajan R Open Heart. 2020; 7(1):e001257.

PMID: 32509316 PMC: 7254112. DOI: 10.1136/openhrt-2020-001257.

Effects of Statins for Secondary Prevention on Functioning and Other Outcomes Among Nursing Home Residents.

Zullo A, Ofori-Asenso R, Wood M, Zuern A, Lee Y, Wu W J Am Med Dir Assoc. 2020; 21(4):500-507.e8.

PMID: 32144051 PMC: 7127965. DOI: 10.1016/j.jamda.2020.01.102.

References

Fried T, Tinetti M, Iannone L, OLeary J, Towle V, Van Ness P . Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions. Arch Intern Med. 2011; 171(20):1854-6. PMC: 4036681. DOI: 10.1001/archinternmed.2011.424. View

Gangavati A, Hajjar I, Quach L, Jones R, Kiely D, Gagnon P . Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc. 2011; 59(3):383-9. PMC: 3306056. DOI: 10.1111/j.1532-5415.2011.03317.x. View

Coelho V, Probst V, Nogari B, Teixeira D, Felcar J, Santos D . Angiotensin-II blockage, muscle strength, and exercise capacity in physically independent older adults. J Phys Ther Sci. 2016; 28(2):547-52. PMC: 4793008. DOI: 10.1589/jpts.28.547. View

Piette J, Kerr E . The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006; 29(3):725-31. DOI: 10.2337/diacare.29.03.06.dc05-2078. View

Barzilay J, Cotsonis G, Walston J, Schwartz A, Satterfield S, Miljkovic I . Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged >or=70 years. Diabetes Care. 2009; 32(4):736-8. PMC: 2660450. DOI: 10.2337/dc08-1781. View

Jyrkka J, Enlund H, Lavikainen P, Sulkava R, Hartikainen S . Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf. 2011; 20(5):514-22. DOI: 10.1002/pds.2116. View

Tomlinson S, Mangione K . Potential adverse effects of statins on muscle. Phys Ther. 2005; 85(5):459-65. View

Savo A, Maiorano P, Onder G, Bernabei R . Pharmacoepidemiology and disability in older adults: can medications slow the age-related decline in physical function?. Expert Opin Pharmacother. 2004; 5(2):407-13. DOI: 10.1517/14656566.5.2.407. View

Yancy C, Jessup M, Bozkurt B, Butler J, Casey Jr D, Drazner M . 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 62(16):e147-239. DOI: 10.1016/j.jacc.2013.05.019. View

10.

Forrest K, Zmuda J, Cauley J . Patterns and determinants of muscle strength change with aging in older men. Aging Male. 2006; 8(3-4):151-6. DOI: 10.1080/13685530500137840. View

11.

Galindo-Ocana J, Bernabeu-Wittel M, Formiga F, Fuertes-Martin A, Baron-Franco B, Murcia-Zaragoza J . Effects of renin-angiotensin blockers/inhibitors and statins on mortality and functional impairment in polypathological patients. Eur J Intern Med. 2012; 23(2):179-84. DOI: 10.1016/j.ejim.2011.06.004. View

12.

Wu J, Haan M, Liang J, Ghosh D, Gonzalez H, Herman W . Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol. 2003; 13(5):369-76. DOI: 10.1016/s1047-2797(02)00464-7. View

13.

Stuck A, Walthert J, Nikolaus T, Bula C, Hohmann C, Beck J . Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med. 1999; 48(4):445-69. DOI: 10.1016/s0277-9536(98)00370-0. View

14.

Smith Jr S, Benjamin E, Bonow R, Braun L, Creager M, Franklin B . AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011; 124(22):2458-73. DOI: 10.1161/CIR.0b013e318235eb4d. View

15.

. Universal health outcome measures for older persons with multiple chronic conditions. J Am Geriatr Soc. 2012; 60(12):2333-41. PMC: 3521090. DOI: 10.1111/j.1532-5415.2012.04240.x. View

16.

Nathan D, Buse J, Davidson M, Ferrannini E, Holman R, Sherwin R . Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2008; 32(1):193-203. PMC: 2606813. DOI: 10.2337/dc08-9025. View

17.

Lorgunpai S, Grammas M, Lee D, McAvay G, Charpentier P, Tinetti M . Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition. PLoS One. 2014; 9(2):e89447. PMC: 3934884. DOI: 10.1371/journal.pone.0089447. View

18.

Simon C, Lee-McMullen B, Phelan D, Gilkes J, Carter C, Buford T . The renin-angiotensin system and prevention of age-related functional decline: where are we now?. Age (Dordr). 2015; 37(1):9753. PMC: 4320995. DOI: 10.1007/s11357-015-9753-5. View

19.

Gray S, Boudreau R, Newman A, Studenski S, Shorr R, Bauer D . Angiotensin-converting enzyme inhibitor and statin use and incident mobility limitation in community-dwelling older adults: the Health, Aging and Body Composition study. J Am Geriatr Soc. 2011; 59(12):2226-32. PMC: 3389784. DOI: 10.1111/j.1532-5415.2011.03721.x. View

20.

Allore H, Zhan Y, Tinetti M, Trentalange M, McAvay G . Longitudinal average attributable fraction as a method for studying time-varying conditions and treatments on recurrent self-rated health: the case of medications in older adults with multiple chronic conditions. Ann Epidemiol. 2015; 25(9):681-686.e4. PMC: 4547873. DOI: 10.1016/j.annepidem.2015.03.022. View